Terms: = Skin cancer AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Prognosis
54 results:
1. Case report: Successful treatment of Chidamide in a refractory/recurrent SPTCL with ARID1A mutation on the basis of chop plus auto-HSCT.
Zhang N; Zhang S; Ma L; Qiu L; Meng QL; Cai J; Xu Z; Yao H; Fan FY
Medicine (Baltimore); 2023 Oct; 102(40):e35413. PubMed ID: 37800816
[TBL] [Abstract] [Full Text] [Related]
2. Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas.
Ribereau-Gayon E; Donzel M; Pham F; Romain-Scelle N; Perier-Muzet M; Balme B; Traverse-Glehen A; Ghesquières H; Dalle S
Leuk Lymphoma; 2023; 64(8):1424-1432. PubMed ID: 37255021
[TBL] [Abstract] [Full Text] [Related]
3. Clinical prognostic risk analysis and progression factor exploration of primary breast lymphoma.
Deng J; Mi L; Wang X; Zhu J; Zhang C; Song Y
Hematology; 2022 Dec; 27(1):1272-1281. PubMed ID: 36476227
[TBL] [Abstract] [Full Text] [Related]
4. Intravascular Large B-Cell Lymphoma: A Review with a Focus on the Prognostic Value of skin Involvement.
Breakell T; Waibel H; Schliep S; Ferstl B; Erdmann M; Berking C; Heppt MV
Curr Oncol; 2022 Apr; 29(5):2909-2919. PubMed ID: 35621627
[TBL] [Abstract] [Full Text] [Related]
5. Primary cutaneou
